Impact Stories
Select the tiles below to learn how our partnerships are making a difference.
Stuart's Opera House
Stuart’s Opera House and Osteopathic Heritage Foundation Partner to Support Arts Education in Southeastern Ohio
Columbus State
Columbus State and Osteopathic Heritage Foundation Partner to Address Healthcare Needs in Franklin County.
317 Board
The Athens Hocking Vinton Alcohol, Drug Addiction and Mental Health Services Board (317 Board) is part of Ohio’s county and regional network of agencies responsible for planning, developing, funding and evaluating a community-based system of care for individuals in need of behavioral health and substance use disorder services.
Andrea Amalfitano, DO, PhD
Developing technology to turn viruses into safe, effective and scalable gene therapies.
Brian J. Balin, PhD
Illuminating new understandings of neurodegenerative conditions and treatment.
Cory Baumann, PHD, FACSM
Exploring solutions for maintaining and improving muscle strength during aging.
Elizabeth A. Beverly, PhD
Pioneering the use of virtual reality to improve the lives of patients with diabetes.
Thomas Cavalieri, DO
Translating research in aging, osteopathic medicine and chronic disease into improved primary care for older adults.
Brian Clark, PhD
Prevention and treatment of age-related muscle weakness and bone fractures.
Leslie Consitt, PhD
Developing type 2 diabetes interventions by advancing insulin resistance research.
Brian F. Degenhardt, DO
Demonstrating the effectiveness of osteopathic manipulative medicine in patient care.
Berkeley Franz, PHD
Increasing access to evidence-based treatment for opioid use disorder.
John C. Licciardone, DO
Increasing access to evidence-based treatment for chronic low back pain, helping patients recover and experience improved health.
Chunmin Lo, PhD
Making breakthrough discoveries of the role of APOA4 in addressing obesity and metabolic diseases.
Graciela Muniz-Terrera, PhD
Uncovering epidemiological insights that promote brain health during aging.
Sonia Najjar, PhD
Advancing understanding of how insulin clearance in the liver causes insulin resistance in the development of obesity, fatty liver disease, high blood pressure, atherosclerosis and heart disease.
Craig Nunemaker, PhD
Innovating new therapeutic approaches for managing diabetes.
Vishwajeet Puri, PhD
Leveraging CIDE protein discoveries into preventative therapies for cardiometabolic diseases.
Shouan Zhu, PHD
Pioneering new ways to understand and relieve osteoarthritis joint pain.